Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  3,279 results for ""Immunotherapy, Active""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors.

  • Authors : Vernet R; Centre for Translational Research in Onco-Hematology, University of Geneva, Geneva, Switzerland.; Swiss Cancer Center Léman (SCCL), Lausanne, Switzerland.

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/therapeutic use

  • Source: Cancer research communications [Cancer Res Commun] 2024 Aug 01; Vol. 4 (8), pp. 2089-2100.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Association of active immunotherapy with outcomes in cancer patients with COVID-19: a systematic review and meta-analysis.

  • Authors : Cao C; State Key Laboratory of Oral Diseases, West China Hospital of Stomatology/Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P.R. China.; Gan X

Subjects: Immunotherapy, Active*/Immunotherapy, Active*/Immunotherapy, Active*/adverse effects ; Immunotherapy, Active*/Immunotherapy, Active*/Immunotherapy, Active*/statistics & numerical data; COVID-19/COVID-19/COVID-19/*diagnosis

  • Source: Aging [Aging (Albany NY)] 2022 Mar 10; Vol. 14 (5), pp. 2062-2080. Date of Electronic Publication: 2022 Mar 10.Publisher: Impact Journals, LLC Country of Publication: United States NLM ID: 101508617 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Targeting alpha-synuclein via the immune system in Parkinson's disease: Current vaccine therapies.

  • Authors : Fleming SM; Department of Pharmaceutical Sciences, Northeast Ohio Medical University, USA. Electronic address: .; Davis A

Subjects: Immune System/Immune System/Immune System/*immunology ; Immunotherapy/Immunotherapy/Immunotherapy/*methods ; Immunotherapy, Active/Immunotherapy, Active/Immunotherapy, Active/*methods

  • Source: Neuropharmacology [Neuropharmacology] 2022 Jan 01; Vol. 202, pp. 108870. Date of Electronic Publication: 2021 Nov 03.Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

[In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?]

  • Authors : Lanthier L; Département de médecine spécialisé, service de médecine interne générale, Université de Sherbrooke, Sherbrooke, QC, Canada. Electronic address: .; Carignan A

Subjects: COVID-19/COVID-19/COVID-19/*therapy ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*therapeutic use ; Immunotherapy, Active/Immunotherapy, Active/Immunotherapy, Active/*adverse effects

  • Source: La Revue de medecine interne [Rev Med Interne] 2021 Mar; Vol. 42 (3), pp. 227-228. Date of Electronic Publication: 2021 Feb 10.Publisher: Elsevier Country of Publication: France NLM ID: 8101383 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3122

Record details

Read More Add to Saved list
×
Academic Journal

Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer.

  • Authors : Waki K; Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Japan.; Yokomizo K

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*administration & dosage ; Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/Carcinoma, Non-Small-Cell Lung/*blood

  • Source: Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2021 Apr; Vol. 43 (2), pp. 176-182. Date of Electronic Publication: 2021 Feb 04.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8800150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Dendritic cell vaccine therapy for colorectal cancer.

  • Authors : Wooster AL; Department of Immunotherotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX, 79601, United States.; Girgis LH

Subjects: Immunotherapy, Active*; Colorectal Neoplasms/Colorectal Neoplasms/Colorectal Neoplasms/*therapy ; Dendritic Cells/Dendritic Cells/Dendritic Cells/*transplantation

  • Source: Pharmacological research [Pharmacol Res] 2021 Feb; Vol. 164, pp. 105374. Date of Electronic Publication: 2020 Dec 28.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer.

  • Authors : Lim CJ; Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, Singapore.; Nguyen PHD

Subjects: Immunotherapy, Active*; BCG Vaccine/BCG Vaccine/BCG Vaccine/*therapeutic use ; Carcinoma, Transitional Cell/Carcinoma, Transitional Cell/Carcinoma, Transitional Cell/*drug therapy

  • Source: Frontiers in immunology [Front Immunol] 2021 Jan 29; Vol. 11, pp. 615091. Date of Electronic Publication: 2021 Jan 29 (Print Publication: 2020).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Progress of immunotherapy of anti-α-synuclein in Parkinson's disease.

  • Authors : Wang Z; Department of Neurobiology School of Basic Medical Sciences, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory for Neural Regeneration and Repair, Beijing Key Laboratory on Parkinson's Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Capital Medical University, Beijing, 100069, China.; Gao G

Subjects: Immunization, Passive* ; Immunotherapy, Active*; Antibodies/Antibodies/Antibodies/*therapeutic use

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2019 Jul; Vol. 115, pp. 108843. Date of Electronic Publication: 2019 May 02.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

New approaches to immunotherapy for metastatic castration-resistant prostate cancer.

  • Authors : Subudhi SK; The University of Texas MD Anderson Cancer Center, Houston, Texas.

Subjects: Immunotherapy, Active*; Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*secondary ; Cancer Vaccines/Cancer Vaccines/Cancer Vaccines/*therapeutic use

  • Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2019 May; Vol. 17 (5), pp. 283-286.Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance.

  • Authors : Kennedy DA; Center for Infectious Disease Dynamics, Departments of Biology and Entomology, The Pennsylvania State University, University Park, PA 16802 .; Read AF

Subjects: Drug Resistance, Microbial* ; Immunotherapy, Active*; Animals

  • Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Dec 18; Vol. 115 (51), pp. 12878-12886. Date of Electronic Publication: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  3,279 results for ""Immunotherapy, Active""